Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

NobelActive TiUltra WP 5.5x7mm: medical device reports filed with FDA

1,326 reports name it, 2020–2026. Manufacturer given most often on reports: Nobel Biocare. Product code DZE.

1,326
device reports naming the brand
0% of all MAUDE reports · about 238 a year
342
reports, 12 months to August 2026
270 in the 12 months before
0.9%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

1,326 medical device reports received by FDA name the brand "NobelActive TiUltra WP 5.5x7mm" (endosseous dental implant); the manufacturer given most often on reports is Nobel Biocare; received from December 2020 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

342 reports arrived in the 12 months to August 2026, up 27% from 270 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (99.1%) and malfunction (0.9%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (63.8%), loss of osseointegration (23.4%) and osseointegration problem (6.3%). The patient problems coded most often are failure of implant, pain and numbness. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

03162Sep 2021: 10Oct 2021: 6Nov 2021: 10Dec 2021: 122022Jan 2022: 12Feb 2022: 14Mar 2022: 18Apr 2022: 12May 2022: 20Jun 2022: 14Jul 2022: 12Aug 2022: 4Sep 2022: 11Oct 2022: 23Nov 2022: 16Dec 2022: 162023Jan 2023: 12Feb 2023: 14Mar 2023: 38Apr 2023: 26May 2023: 26Jun 2023: 8Jul 2023: 18Aug 2023: 18Sep 2023: 22Oct 2023: 20Nov 2023: 28Dec 2023: 102024Jan 2024: 18Feb 2024: 34Mar 2024: 26Apr 2024: 22May 2024: 36Jun 2024: 24Jul 2024: 20Aug 2024: 26Sep 2024: 32Oct 2024: 28Nov 2024: 22Dec 2024: 82025Jan 2025: 24Feb 2025: 14Mar 2025: 44Apr 2025: 2May 2025: 0Jun 2025: 2Jul 2025: 62Aug 2025: 32Sep 2025: 38Oct 2025: 24Nov 2025: 34Dec 2025: 282026Jan 2026: 22Feb 2026: 36Mar 2026: 28Apr 2026: 22May 2026: 32Jun 2026: 26Jul 2026: 18Aug 2026: 34

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01523042020: 420202021: 9220212022: 17220222023: 24020232024: 29620242025: 30420252026: 2182026

Event type and report source

Event type, as classified on the report

Death0%0
Injury99.1%1,314
Malfunction0.9%12
Other0%0
Not given0%0

Who filed the report

Manufacturer report50%663
Voluntary report0%0
User facility report0%0
Distributor report50%663
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate84663.8%62.8%
Loss of osseointegration31023.4%22.4%
Osseointegration problem846.3%7.7%
Patient device interaction problem161.2%0.3%
Migrationthe device moved from where it was placed141.1%0.1%
Fracturea broken bone80.6%1.6%
Premature separation80.6%0.1%
Difficult to insertthe device was hard to insert40.3%0.4%
Mechanical problema mechanical problem40.3%0.1%
Activation, positioning or separation problem20.2%0%
Device markings/labelling problema problem with the device markings or label20.2%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant85664.6%
Painpain, site not specified1108.3%
Numbnessnumbness262%
Abscessa collection of pus161.2%
Hypersensitivity/allergic reaction161.2%
Inflammationinflammation161.2%
Fistula80.6%
Foreign body in patientpart of a device left in the patient80.6%
Implant pain80.6%
Sinus perforation80.6%
Appropriate clinical signs, symptoms and conditions term/code not available60.5%
Bone fracture(s)60.5%
Osteomyelitis40.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureNobelActive TiUltra WP 5.5x7mmProduct code DZEAll MAUDE reports
Reports1,3263,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury99.1%99.2%36.2%
Classified as malfunction0.9%0.8%62.3%
Filed by the manufacturer50%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about NobelActive TiUltra WP 5.5x7mm reports

How many FDA reports name NobelActive TiUltra WP 5.5x7mm?

1,326 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 342 in the latest 12 months.

What kinds of events are reported?

injury (99.1%) and malfunction (0.9%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (63.8%), loss of osseointegration (23.4%), osseointegration problem (6.3%), patient device interaction problem (1.2%) and migration (1.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (50%) and distributor reports (50%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that NobelActive TiUltra WP 5.5x7mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.